Alessandro Poli

Dr. Alessandro Poli

FIRC Institute of Molecular Oncology (IFOM), 20139 Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2017 in Anticancer Research
Verified
Journal Article
Open access
PDF file
ABAlberto Bavelloni
Alberto Bavelloni
GRGiulia Ramazzotti
Giulia Ramazzotti
Alessandro PoliAlessandro Poli
Alessandro Poli
MPManuela Piazzi
Manuela Piazzi
EFEnrico Focaccia
Enrico Focaccia
Irene FaenzaIrene Faenza
Irene Faenza
MicroRNAs (miRNAs) are a group of highly conserved small non-coding RNAs that were found to enhance mRNA degradation or inhibit post-transcriptional translation. Accumulating evidence indicates that miRNAs contribute to tumorigenesis and cancer metastasis. microRNA-210 has been largely studied in the past several years and has been identified as a major miRNA induced under hypoxia. A variety of miR-210 targets have been identified pointing to its role, not only in mitochondrial metabolism, but also in angiogenesis, the DNA damage response, cell proliferation, and apoptosis. Based on earlier research findings, this review aims to provide a current overview on the involvement of miRNA-210 in biological processes and diseases.

1 January 2015 in Advances in Biological Regulation
Verified
Journal Article
Closed access
MFMatilde Yung Follo
Matilde Yung Follo
LMLucia Manzoli
Lucia Manzoli
Alessandro PoliAlessandro Poli
Alessandro Poli
JMJames A. McCubrey
James A. McCubrey
Lucio CoccoLucio Cocco
Lucio Cocco

Verified
Journal Article
Open access
PDF file
RFRoberta Fiume
Roberta Fiume
Irene FaenzaIrene Faenza
Irene Faenza
BSBhavwanti Sheth
Bhavwanti Sheth
Alessandro PoliAlessandro Poli
Alessandro Poli
MVMagdalena C Vidalle
Magdalena C Vidalle
NDNullin Divecha
Nullin Divecha
Polyphosphoinositides (PPIns) are a family of seven lipid messengers that regulate a vast array of signalling pathways to control cell proliferation, migration, survival and differentiation. PPIns are differentially present in various sub-cellular compartments and, through the recruitment and regulation of specific proteins, are key regulators of compartment identity and function. Phosphoinositides and the enzymes that synthesise and degrade them are also present in the nuclear membrane and in nuclear membraneless compartments such as nuclear speckles. Here we discuss how PPIns in the nucleus are modulated in response to external cues and how they function to control downstream signalling. Finally we suggest a role for nuclear PPIns in liquid phase separations that are involved in the formation of membraneless compartments within the nucleus.

18 September 2014 in Biochemical Society Transactions
Verified
Journal Article
Closed access
PDF file
Alessandro PoliAlessandro Poli
Alessandro Poli
SMSara Mongiorgi
Sara Mongiorgi
LCLucio Cocco
Lucio Cocco
MFMatilde Y. Follo
Matilde Y. Follo
Protein kinases C (PKCs) are a family of serine/threonine kinases which act as key regulators in cell cycle progression and differentiation. Studies of the involvement of PKCs in cell proliferation showed that their role is dependent on cell models, cell cycle phases, timing of activation and localization. Indeed, PKCs can positively and negatively act on it, regulating entry, progression and exit from the cell cycle. In particular, the targets of PKCs resulted to be some of the key proteins involved in the cell cycle including cyclins, cyclin-dependent kinases (Cdks), Cip/Kip inhibitors and lamins. Several findings described roles for PKCs in the regulation of G1/S and G2/M checkpoints. As a matter of fact, data from independent laboratories demonstrated PKC-related modulations of cyclins D, leading to effects on the G1/S transition and differentiation of different cell lines. Moreover, interesting data were published on PKC-mediated phosphorylation of lamins. In addition, PKC isoenzymes can accumulate in the nuclei, attracted by different stimuli including diacylglycerol (DAG) fluctuations during cell cycle progression, and target lamins, leading to their disassembly at mitosis. In the present paper, we briefly review how PKCs could regulate cell proliferation and differentiation affecting different molecules related to cell cycle progression.

28 December 2015 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Alessandro PoliAlessandro Poli
Alessandro Poli
ABAnna Maria Billi
Anna Maria Billi
SMSara Mongiorgi
Sara Mongiorgi
SRstefano ratti
stefano ratti
JMJames A. McCubrey
James A. McCubrey
GRGIULIA RAMAZZOTTI
GIULIA RAMAZZOTTI

Verified
Journal Article
Open access
PDF file
Alessandro PoliAlessandro Poli
Alessandro Poli
AZAntonio Enrico Zaurito
Antonio Enrico Zaurito
SHShidqiyyah Abdul Hamid
Shidqiyyah Abdul Hamid
RFRoberta Fiume
Roberta Fiume
Irene FaenzaIrene Faenza
Irene Faenza
NDNullin Divecha
Nullin Divecha
Phosphatidylinositol (PI)-related signaling plays a pivotal role in many cellular aspects, including survival, cell proliferation, differentiation, DNA damage, and trafficking. PI is the core of a network of proteins represented by kinases, phosphatases, and lipases which are able to add, remove or hydrolyze PI, leading to different phosphoinositide products. Among the seven known phosphoinositides, phosphatidylinositol 5 phosphate (PI5P) was the last to be discovered. PI5P presence in cells is very low compared to other PIs. However, much evidence collected throughout the years has described the role of this mono-phosphoinositide in cell cycles, stress response, T-cell activation, and chromatin remodeling. Interestingly, PI5P has been found in different cellular compartments, including the nucleus. Here, we will review the nuclear role of PI5P, describing how it is synthesized and regulated, and how changes in the levels of this rare phosphoinositide can lead to different nuclear outputs.